Logo
x

Search

Subscribe Now

AZD7442

AstraZeneca's AZD7442 Meets its Primary Endpoint in P-III PROVENT Study for the Prevention of COVID-19

AstraZeneca's AZD7442 Meets its Primary Endpoint in P-III PROVENT Study for the Prevention of COVID-19

  • August 20, 2021
AstraZeneca Advances its AZD7442 in Two P-III Clinical Studies for COVID-19

AstraZeneca Advances its AZD7442 in Two P-III Clinical Studies for COVID-19

  • October 12, 2020
AstraZeneca Initiates P-I Study of AZD7442 Against COVID-19

AstraZeneca Initiates P-I Study of AZD7442 Against COVID-19

  • August 25, 2020
Image

Incisive News in 3 Shots.

Contact Us

Our Information

Follow Us

Copyright © 2024 PharmaShots - All Rights Reserved.